共 50 条
- [25] Real-world impact of empagliflozin on total cost of care in adults with type 2 diabetes: Results from an outcomes-based agreement JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023, 29 (02): : 152 - 160
- [26] The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q PharmacoEconomics - Open, 2019, 3 : 351 - 358
- [28] Real-world adherence to erenumab, rescue medication utilization, and work absenteeism for patients with migraine: Results from an outcomes-based agreement JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2025, 31 (03): : 236 - 244